Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
6.71M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
187K
-
Shares change
-
-78.3K
-
Total reported value, excl. options
-
$434K
-
Value change
-
-$444K
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$2.22
Significant Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q2 2024
20 filings reported holding VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q2 2024.
Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187K shares
of 6.71M outstanding shares and own 2.78% of the company stock.
Largest 10 shareholders include Strategic Wealth Investment Group, LLC (129K shares), GEODE CAPITAL MANAGEMENT, LLC (20.7K shares), COMMONWEALTH EQUITY SERVICES, LLC (16K shares), VANGUARD GROUP INC (10.6K shares), Triad Wealth Partners, LLC (2.82K shares), Credit Agricole S A (2.37K shares), Tower Research Capital LLC (TRC) (2.28K shares), Newbridge Financial Services Group, Inc. (1.28K shares), OSAIC HOLDINGS, INC. (898 shares), and SIGNATUREFD, LLC (547 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.